|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
|
|---|---|---|---|
| Operating costs and expenses: | |||
| Cost of sales | |||
| Selling, general and administrative | |||
| Loss on divestiture of asbestos-related assets and liabilities | |||
| Operating profit | |||
| Other income (expense): | |||
| Interest income | |||
| Interest expense | |||
| Gain on sale of business | |||
| Miscellaneous income, net | |||
| Total other income (expense), net | |||
| Income from continuing operations before income taxes | |||
| Effective Tax Rate | |||
| Net income from continuing operations attributable to common shareholders | |||
| Income from discontinued operations, net of tax (Note 3) | |||
| Earnings Per Share | |||
| Earnings per basic share from continuing operations (in dollars per share) | |||
| Earnings per basic share from discontinued operations (in dollars per share) | |||
| Basic earnings per share (in dollars per share) | |||
| Earnings per diluted share from continuing operations (in dollars per share) | |||
| Earnings per diluted share from discontinued operations (in dollars per share) | |||
| Diluted earnings per share (in dollars per share) | |||
| Average shares outstanding: | |||
| Weighted average basic shares outstanding (in shares) | |||
| Weighted average diluted shares outstanding (in shares) | |||
| Net sales | |||
| Engineering, Selling, General And Administrative Expense |
Loading...
